AGIO
Price
$27.71
Change
-$0.73 (-2.57%)
Updated
Apr 3 closing price
Capitalization
1.59B
27 days until earnings call
CORT
Price
$79.37
Change
-$4.44 (-5.30%)
Updated
Apr 3 closing price
Capitalization
8.38B
26 days until earnings call
Ad is loading...

AGIO vs CORT

Header iconAGIO vs CORT Comparison
Open Charts AGIO vs CORTBanner chart's image
Agios Pharmaceuticals
Price$27.71
Change-$0.73 (-2.57%)
Volume$634.78K
Capitalization1.59B
Corcept Therapeutics
Price$79.37
Change-$4.44 (-5.30%)
Volume$2.09M
Capitalization8.38B
AGIO vs CORT Comparison Chart
Loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGIO vs. CORT commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Hold and CORT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (AGIO: $27.71 vs. CORT: $79.37)
Brand notoriety: AGIO and CORT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 94% vs. CORT: 135%
Market capitalization -- AGIO: $1.59B vs. CORT: $8.38B
AGIO [@Biotechnology] is valued at $1.59B. CORT’s [@Biotechnology] market capitalization is $8.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileCORT’s FA Score has 2 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • CORT’s FA Score: 2 green, 3 red.
According to our system of comparison, CORT is a better buy in the long-term than AGIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 4 TA indicator(s) are bullish while CORT’s TA Score has 6 bullish TA indicator(s).

  • AGIO’s TA Score: 4 bullish, 6 bearish.
  • CORT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CORT is a better buy in the short-term than AGIO.

Price Growth

AGIO (@Biotechnology) experienced а -10.15% price change this week, while CORT (@Biotechnology) price change was +40.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

AGIO is expected to report earnings on May 01, 2025.

CORT is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CORT($8.38B) has a higher market cap than AGIO($1.59B). CORT has higher P/E ratio than AGIO: CORT (64.59) vs AGIO (2.44). CORT YTD gains are higher at: 57.511 vs. AGIO (-15.673). CORT has higher annual earnings (EBITDA): 138M vs. AGIO (-420.08M). AGIO has more cash in the bank: 894M vs. CORT (383M). CORT has less debt than AGIO: CORT (6.94M) vs AGIO (57M). CORT has higher revenues than AGIO: CORT (675M) vs AGIO (36.5M).
AGIOCORTAGIO / CORT
Capitalization1.59B8.38B19%
EBITDA-420.08M138M-304%
Gain YTD-15.67357.511-27%
P/E Ratio2.4464.594%
Revenue36.5M675M5%
Total Cash894M383M233%
Total Debt57M6.94M822%
FUNDAMENTALS RATINGS
AGIO vs CORT: Fundamental Ratings
AGIO
CORT
OUTLOOK RATING
1..100
6587
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
84
Overvalued
PROFIT vs RISK RATING
1..100
10014
SMR RATING
1..100
1840
PRICE GROWTH RATING
1..100
8035
P/E GROWTH RATING
1..100
855
SEASONALITY SCORE
1..100
5046

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGIO's Valuation (42) in the Biotechnology industry is somewhat better than the same rating for CORT (84) in the Pharmaceuticals Other industry. This means that AGIO’s stock grew somewhat faster than CORT’s over the last 12 months.

CORT's Profit vs Risk Rating (14) in the Pharmaceuticals Other industry is significantly better than the same rating for AGIO (100) in the Biotechnology industry. This means that CORT’s stock grew significantly faster than AGIO’s over the last 12 months.

AGIO's SMR Rating (18) in the Biotechnology industry is in the same range as CORT (40) in the Pharmaceuticals Other industry. This means that AGIO’s stock grew similarly to CORT’s over the last 12 months.

CORT's Price Growth Rating (35) in the Pharmaceuticals Other industry is somewhat better than the same rating for AGIO (80) in the Biotechnology industry. This means that CORT’s stock grew somewhat faster than AGIO’s over the last 12 months.

CORT's P/E Growth Rating (5) in the Pharmaceuticals Other industry is significantly better than the same rating for AGIO (85) in the Biotechnology industry. This means that CORT’s stock grew significantly faster than AGIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGIOCORT
RSI
ODDS (%)
Bullish Trend 1 day ago
58%
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
69%
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 16 days ago
77%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 1 day ago
66%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
70%
Aroon
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 4 days ago
68%
View a ticker or compare two or three
Ad is loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIVYX41.20N/A
N/A
Putnam International Capital Opp Y
VWNEX71.17N/A
N/A
Vanguard Windsor™ Admiral™
NMSCX21.25N/A
N/A
Columbia Small Cap Index Inst
JSCZX15.02N/A
N/A
JPMorgan US Small Company R2
BAFMX15.91N/A
N/A
Brown Advisory Mid-Cap Growth Instl

CORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CORT has been loosely correlated with TENX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CORT jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORT
1D Price
Change %
CORT100%
-5.30%
TENX - CORT
41%
Loosely correlated
-4.76%
FHTX - CORT
41%
Loosely correlated
-7.89%
AGIO - CORT
41%
Loosely correlated
-2.57%
DNLI - CORT
40%
Loosely correlated
-6.91%
ARCT - CORT
37%
Loosely correlated
-7.01%
More